Antimicrobial and Antioxidant Activities of Extracts and Compounds From Trifolium Baccarinii With Their Mechanisms of Antibacterial Action

The treatment of infectious diseases with antimicrobial agents continues to present problems in modern-day medicine with many studies showing signicant increase in the incidence of bacterial resistance to several antibiotics. The screening of plant extracts and natural compounds for antimicrobial activity has demonstrated that higher plants represent a potential source of new anti-infective agents. The aim of this study was to evaluate the antimicrobial and antioxidant activities of extracts and compounds from the whole plant Trifolium baccarinii Chiov. with their mechanisms of antibacterial action. Biochanin A (1), formononetin (2), luteolin (3), luteolin-4'-O-β-D-glucopyranoside (4), 4,7,2'-trihydroxy-4'-methoxyisoavanol (5), sissotrin (6), 1-méthyl-β-D-glucopyranoside (7), ononin (8), D-mannitol (9) and 3-O-β-D-glucuronopyranosylsoyasapogenol B (10) were isolated from T. baccarinii. The MeOH, EtOAc and n-BuOH extracts as well as compounds 1–6 from T. baccarinii displayed the most antimicrobial and antioxidant activities. The MeOH extract and compound 5 exhibited antibacterial activity through bacteriolytic effect and reduction of the antioxidant defenses in the bacterial cells. Interestingly, none of the tested samples showed cytotoxic activity against normal cells; highlighting their good selectivity toward pathogenic bacteria and yeasts. Hence, they are promising lead candidates with antibacterial potential against methicillin resistant S. aureus (MRSA). (MHB) for One hundred microliters each and ﬁ to Plates and on and °C during h, h and for bacteria, Candida and neoformans, after the corresponding incubation and were taken as the lowest sample concentration at which there was no growth or virtually no growth.


Introduction
The treatment of infectious diseases with antimicrobial agents continues to present problems in modern-day medicine with many studies showing signi cant increase in the incidence of bacterial resistance to several antibiotics 1 . The expansion of antimicrobial resistance is accelerated by the selective pressure exerted by widespread use and misuse of antimicrobial drugs in both humans and food-producing animals. Antimicrobial resistance is a complex global public health challenge that leads to prolonged illness and increased mortality, increases the costs for the health-care sector, and has an impact on animal health, which probably leads to an effect on food production 2 . As a case in point, over time, the original Gram-positive bacterium Staphylococcus aureus developed resistance towards a series of rst-line, second-line and even third-line antibiotics 3 to evolve into methicillin-resistant S. aureus (MRSA). Now, as MRSA is able to resist the beta-lactam group of antibiotics, the treatment of this highly prevalent pathogen has become an urgent challenge. In organisms, free radicals such as reactive oxygen species (ROS) are formed normally during processes such as cell respiration and have important roles in cell signaling 4 . It is well known that ROS production is rapidly elevated during infection, serving to facilitate pathogen clearance as well as contributing to signaling cascades related to in ammation, cell proliferation, and immune responses 5 . However, high amounts of the free radicals produced during infection can cause oxidative stress; which further complicates the patient's life prognosis.
Due to increased resistance of many microorganisms towards established antimicrobials, much recent attention has been paid to extracts and active principles isolated from plant species used in traditional medicine 6 . The screening of plant extracts and natural compounds for antimicrobial activity has demonstrated that higher plants represent a potential source of new anti-infective agents. Crude extracts from medicinal plants have proved to be clinically effective and relatively less toxic than the existing antibiotics 7 . Phytochemical compounds, particularly avonoids and other natural compounds play an important role in the defense against free radicals and pathogenic microorganisms 8,9 . Hence, there is a justi able need to explore for new and more potent antimicrobial/antioxidant compounds of natural origin to combat infectious diseases associated with drug-resistant microorganisms and oxidative stress.
Plants of the genus Trifolium are widespread throughout the world and represented in a total of four oristic regions: Neotropic, Paleotropic, Holarctic and Capensis. They are generally small herbaceous plants, some creeping, which can be perennial, annual or biennial. The species of the genus Trifolium are characterized by their capacity to x atmospheric nitrogen through symbiotic bacteria hosted in their roots. The leaves are generally with three lea ets (sometimes four), and are at the origin of the name of the genus. The lea ets are almost always toothed, sometimes smudged at their center. Trifolium baccarinii Chiov (Fabaceae) is an annual herb, glabrous or sparingly hairy in upper parts, 7-50 cm tall. The stems are erect, ascending or prostrate and sometimes rooting at nodes in overgrazed areas, grooved and branched. It is a plant of montane grassland at elevations 1,600 m and over in West Cameroon, and widespread in East Cameroon to Ethiopia and East Africa south-wards to Democratic Republic of Congo and Tanzania. In the Cameroonian folk medicine, T. baccarinii is used for treatment of various diseases such as dermatosis, pulmonary infections, coughs, fevers and rheumatisms. Some Trifolium species are reported to contain iso avones, avonoids, pterocarpans, saponins, coumarins, and tyramine [10][11][12][13] . The antioxidant, anti-in ammatory and antimicrobial properties of some species of Trifolium were determined [12][13][14][15] . To date, however, no scienti c report could be found in the literature regarding the antioxidant and antimicrobial activities of T. baccarinii, although there is an ample ethnobotanical claim for these properties. As a continuing research directed at the biological properties of plants grown in Cameroon, this paper describes the results of the antimicrobial and antioxidant activities of extracts and compounds from T. baccarinii with their mechanisms of antibacterial action.

Methods
General experimental procedures NMR analysis The 1 H and 13 C-NMR spectra were recorded on a Bruker Avance III 600 spectrometer equipped with a cryo-platform ( 1 H at 600 MHz and 13 C at 150 MHz). 2D NMR experiments were performed using standard Bruker microprograms (Xwin-NMR version 2.1 software). All chemical shifts (δ) are reported in parts per million (ppm) with the solvent signal as reference relative to TMS (δ = 0) as internal standard, while the coupling constants (J) are given in Hertz (Hz). Deuterated solvents, methanol (CD 3 OD), dimethyl sulfoxide (DMSO-d 6 ), and chloroform (CDCl 3 ) were used as solvents for the NMR experiments.

Chromatographic methods
Column chromatography was run on Merck silica gel (VWR, France) 60 (70-230 mesh) and gel permeation on Sephadex LH-20 (VWR, France), while TLC was carried out on silica gel GF254 pre-coated plates and the spots were visualized by an UV lamp multiband UV-254/365 nm (ModelUVGL-58 Upland CA 91786, U.S.A) followed by spraying with 50% H 2 SO 4 followed by heating at 100 °C.

Sample collection
The whole plant Trifolium baccarinii Chiov was collected on January 2016 in Dschang, western region of Cameroon. The botanical identi cation was carried out at the National Herbarium of Cameroon after comparison with the samples deposited at the reference number 2976/HNC.

Extraction and Fractionation
The plant material was air-dried at room temperature and ground into ne powder. The dried powder of T. baccarinii (4.5 kg) was extracted at room temperature with methanol (3 × 20L, 72h) to yield 281 g of crude methanol extract after evaporation of solvent under reduced pressure. A part of crude extract (271 g) undergoes a differential solubilization with H 2 O/EtOAc (300 mL / 500 mL) followed by H 2 O/n-BuOH (300 mL / 500 mL). After evaporation of each solvent under reduced pressure, we obtained 70 g of EtOAc and 54 g of n-BuOH extracts.

Microorganisms
The antimicrobial activity was performed against ve bacterial and two fungal species. The selected microorganisms were the Gram-positive (Staphylococcus aureus ATCC25923, methicillin resistant S. aureus MRSA03 and methicillin resistant S. aureus MRSA04) and Gram-negative (Pseudomonas aeruginosa ATCC27853 and Escherichia coli S2(1)) bacteria and yeast strains of Candida albicans ATCC10231 and Cryptococcus neoformans H99. These microorganisms were taken from our laboratory collection. The fungal and bacterial strains were maintained on Sabouraud Dextrose Agar (SDA, Conda, Madrid, Spain) and nutrient agar (NA, Conda) slants respectively.

Determination of minimum inhibitory concentration (MIC) and minimum Microbicidal concentration (MMC)
The antimicrobial activity was investigated by determining the minimum inhibitory concentrations (MICs), minimum bactericidal concentrations (MBC) and minimum fungicidal concentrations (MFCs). MICs of extracts/compounds were monitored using the broth microdilution method 16. Test sample was dissolved in dimethylsulfoxide (DMSO, Fisher chemicals) to give a stock solution that was twofold serially diluted in Mueller-Hinton Broth (MHB) for bacteria and Sabouraud Dextrose Broth (SDB) for fungi to obtain a concentration range of 4096 to 0.25 µg/mL. One hundred microliters of each concentration was introduced into a well (96-wells microplate) containing 90 µL of SDB or MHB and 10 µL of inoculums (at 1 x 10 6 CFU/mL for bacteria and 1 x 10 5 spores/ mL for yeasts) were added to obtain a final concentration range of 2048 to 0.125 µg/mL. Plates were covered and incubated on the shaker at 37°C , 30 °C and 30 °C during 24 h, 48 h and 72 h for bacteria, Candida albicans and Cryptococcus neoformans, respectively. MICs were assessed visually after the corresponding incubation period and were taken as the lowest sample concentration at which there was no growth or virtually no growth.
For the minimum microbicidal concentration (MMC) determination, 10 µL aliquots from each well that showed no growth of microorganism were plated on Mueller-Hinton Agar or Sabouraud Dextrose Agar and incubated as described above. The lowest concentration that yielded no growth after the sub-culturing was taken as the MBCs or MFCs. Oxacillin (Sigma-Aldrich, Steinheim, Germany) for bacteria and nystatin (Sigma-Aldrich, Steinheim, Germany) for yeasts were used as positive controls; while broth with 20 µL of DMSO was used as negative control. The assay was carried out in triplicate and repeated three times with similar results.

Antibacterial Mechanism Studies
The mechanisms of antibacterial action were determined by lysis, salt tolerance assays and antioxidant enzyme activities.

Bacteriolytic assay
The bacteriolytic activity of methanol extract and compound 5, which exhibited the highest antimicrobial activities, was performed against P. aeruginosa and S. aureus using the time-kill kinetic method as previously described 17 with some modi cations. Full growth of bacterium in MHB was diluted 100 times and incubated at 37 °C to produce an OD 600 of 0.8 as starting inoculum. Sample solutions were added to the starting bacterial suspension to give a nal concentration of 2 × MIC and incubated at 37 °C under agitation at 150 rpm. After the incubation period corresponding to 0, 15, 30, 60, 120 and 240 min, 100 µL was removed from each tube and the optical density was recorded at 600 nm using BIOBASE UV-VIS spectrophotometer. Corresponding dilutions of test samples were used as blanks. Oxacillin was used as positive controls and the tubes without extract/compound served as negative controls. All the measurements were done in triplicate and repeated three times with similar results.
Loss of Salt Tolerance in Staphylococcus aureus.
The ability of S. aureus ATCC25923 and methicillin resistant S. aureus MRSA03 cells treated with methanol extract and compound 5 to grow on Mueller Hinton agar (MHA) supplemented with NaCl was investigated. In preliminary experiments, untreated suspensions of S. aureus were plated on MHA supplemented with NaCl from 40 to 100 g/L. Plates were incubated and upon incubation, the resulting colonies were counted. Concentrations of NaCl, 50, 60 and further experimentation steps, suspensions of bacteria were prepared as previously described and treated with MeOH extract or compound 5 at 1/2x MIC, MIC, and 2x MIC. After 1 h incubation, samples were removed, serially diluted, and inoculated onto MHA and MHA-NaCl (50, 60 and 70 g/L). Bacterial culture without sample was used as control for each MHA-NaCl plate. Upon incubation, the numbers of CFU per milliliter on each MHA-NaCl plate were compared to those on the MHA plate, and the result was expressed as a percentage 18 .

Antioxidant enzyme activities
For evaluation of catalase and superoxide dismutase (SOD) activities, S. aureus ATCC25923 and methicillin resistant S. aureus MRSA03 (1.5 × 10 8 CFU/ml, 500 μl) cultures from the late exponential growth phase were treated with MIC and 1/2xMIC of methanol extract (500 μl), compound 5 (500 μl) and oxacillin (500 μl) solutions and incubated at 37 °C for 24 h. The suspension was centrifuged at 3000 rpm for 5 min to separate the supernatant.
Pellet was washed twice with PBS and re-suspended in 500 μl of cell lysate buffer (1 mM EDTA, 10 Mm Tris-HCl, 0.1% Triton-X-100 and 150 mM NaCl) 19 and kept for incubation at 37 °C for 1 h. Contents were then centrifuged at 3000 rpm for 5 min and the supernatant was collected for enzyme activity assays. The GEAC test was done as previously described 20 with slight modi cations. In a quartz cuvette, to 950 µL acetate buffer (pH = 5.0, 100 mM), the following were added: 20 µL laccase (1 mM stock solution), 20 µL test sample, 10 µL ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (74 mM stock solution). The laccase were puri ed from Sclerotinia sclerotiorum according to the protocol described 21 . The sample concentrations in the assay mixture were 800, 400, 200, 100, 10 µg/mL for the extracts and 200, 100, 50, 25, 12.5 µg/mL for the isolated compounds. The content of the generated ABTS •+ radical was measured at 420 nm after 240 s reaction time and was converted to gallic acid equivalents by the use of a calibration curve (Pearson's correlation coefficient: r = 0.998) constructed with 0, 4, 10, 14, 28, 56, 84 µM gallic acid standards rather than Trolox. Experiments were done in triplicate and repeated three times with similar results.
Diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging assay The free radical scavenging activity of extracts and compounds was evaluated according to described method 22 . The EC 50 (µg/ml), which is the amount of sample necessary to inhibit by 50% the absorbance of free radical DPPH was calculated 22 . Vitamin C was used as a standard control. All the analyses were carried out in triplicate and repeated three times with similar results.

Cytotoxicity assay
Wistar rats (Rattus novergicus) aged 10-12 weeks and weighing 220 to 250 g were randomly selected from our colony. All the procedures and protocols involving animals and their care were conducted in conformity with the institutional guidelines and approved by the Cameroon National Ethical Committee (Reg. No. FWA-IRB00001954) and in compliance with the ARRIVE guidelines. Efforts were also made to minimize animal suffering and to reduce the number of animal used in the experiment. All the rats were sacri ced by intraperitoneal injection of the mixture of ketamine (50 mg/ kg) and xylazine (10 mg /kg) for anaesthesia. Whole blood (10 mL) from albino rats was collected by cardiac puncture into a conical tube containing Ethylene Diamine Tetra Acetic Acid (EDTA) as an anticoagulant. Erythrocytes were harvested by centrifugation at room temperature for 10 min at 1,000 x g and were washed three times in PBS buffer 23 . The cytotoxicity was evaluated as previously described 23 .

Statistical analysis
Data were analyzed by one-way analysis of variance followed by Waller-Duncan Post Hoc test. The experimental results were expressed as the mean ± Standard Deviation (SD). Differences between groups were considered signi cant when p < 0.05. All analyses were performed using the Statistical Package for Social Sciences (SPSS, version 12.0) software.

Chemical analysis
The puri cation of the EtOAc and n-BuOH extracts from T. baccarinii led to the isolation of ten known compounds (Fig. 1). The structures of these compounds were established on the basis of spectroscopic data ( 1 H and 13

Antimicrobial activity
The antimicrobial properties of extracts and isolated compounds from T. baccarinii were evaluated against both pathogenic bacteria and fungi by determining their minimum inhibitory concentration (MIC) values and the results are depicted in Table 1. The MeOH, EtOAc and n-BuOH extracts from T. baccarinii were effective in inhibiting the growth of all tested yeasts, Gram-positive and Gram-negative bacteria with MIC values in the range of 32 -512 μg/mL. The MIC values of MeOH and EtOAc extracts were in the range of 32 -64 μg/mL, whereas n-BuOH extract was active in the range of 128 -512 μg/mL towards the tested bacteria and yeasts. This result suggests that the n-BuOH extract was lesser active than the MeOH and EtOAc extracts. Indeed, a lowest MIC value indicates a largest antimicrobial agent as less sample is required to inhibit growth of the microorganism. The lowest MIC value of 8 μg/mL was recorded on C. neoformans with compound 3 and on P. aeruginosa, E. coli, S. aureus, C. albicans and C. neoformans with compound 5 whereas the lowest MMC value was obtained on P. aeruginosa, S. aureus and C. neoformans with compound 5. However, the highest MIC value of 512 μg/mL was recorded with n-BuOH extract against MRSA04, while the highest MMC value of 2048 μg/mL was obtained on MRSA04 with n-BuOH extract.  Table 1, oxacillin and nystatin used as standard drugs were more potent than compound 5 against yeasts, Gram-positive and Gram-negative bacteria with the exception against E. coli where oxacillin was less active compared with compound 5. The most susceptible strains towards the tested samples were P. aeruginosa, E. coli, S. aureus and C. neoformans whereas the most resistant strains were methicillin resistant S. aureus (MRSA03 and MRSA04) and C. albicans.

Mechanism of Antibacterial Activity
Bacteriolytic activity The result on the bacteriolytic activity showed a decrease in the optical density of bacteria suspensions treated with the MeOH extract and compound 5 as a function of time (Fig. 2). Most of the decrease in the optical density was observed during the rst periods of incubation (30, 60 and 120 min) followed by a slight decrease in the optical density after 120 min of incubation. After 240 min, the MeOH extract and compound 5 induced a decline in cell turbidity of 97.08 and 99.85% in P. aeruginosa suspension and of 99.79 and 99.87% in S. aureus ATCC25923 suspension, respectively compared to the 0 time value, indicating the lysis of bacterial cells. Treatment with oxacillin had no effect (decline in cell turbidity of 2% to the 0 time value).

Loss of Salt Tolerance in Staphylococcus aureus
The effect of different concentrations of T. baccarinii MeOH extract (a) and compound 5 (b) on the reduction of salt tolerance of S. aureus is shown in Fig. 3. It can be noted that when the bacteria pretreated with samples were inoculated on culture media supplemented with different concentrations of NaCl, a signi cant decrease in the number of colony-forming units was observed depending on the pretreatment concentrations of the MeOH extract/compound 5. Compared to other concentrations, the largest reductions in the number of colonies formed were observed on culture medium supplemented at 70% NaCl with two times the MICs.

Antioxidant enzyme activities
Cell lysates treated with methanol extract, compound 5 and oxacillin showed signi cant concentration-dependent decreases in catalase and SOD activities compared to those of untreated cell lysates (negative control) (Fig. 4). Also, treatment with MIC of MeOH extract, compound 5 and oxacillin displayed the most signi cant decreases in catalase and SOS activities when compared to their 1/2xMIC treatment against Staphylococcus aureus ATCC25923 and MRSA03. The effect of compound 5 on the catalase and SOS activities was signi cantly greater than those of oxacillin and MeOH extract.

Antioxidant activity
The extracts and their isolated compounds were evaluated for their antioxidant activity using DPPH and TEAC methods ( Table 2).The DPPH• and ABTS•+ radical scavenging activities were observed in all the extracts. The lowest IC 50 value reflects the highest DPPH radical scavenging activity whereas the largest gallic acid equivalent antioxidant capacity represents the highest ABTS•+ radical scavenging activity. According to the results obtained, the n-BuOH extract was the most potent antioxidant extract followed in decreasing order by the MeOH extract and EtOAc extract. Compounds 7, 9, and 10 were found to be inactive in both DPPH and TEAC assays. Compound 4 was the most active antioxidant compound followed in decreasing order by compounds 1, 2, 6, 3, 5 and 8.

Cytotoxic activity
The cytotoxic activity of extracts and isolated compounds from T. baccarinii against red blood cells (RBCs) was investigated using Triton X-100 as a positive control. The positive control showed about 100% lysis, whereas the phosphate buffer saline (PBS) showed no lysis of RBCs. Interestingly, none of the tested extracts and compounds showed cytotoxic activity against RBCs at concentrations up to 2048 μg/mL for the extracts and 256 μg/mL for the isolated compounds (results not shown).

Discussion
The antimicrobial activity of the MeOH extract was comparable with that of the EtOAc extract but higher than that of the n-BuOH extract, indicating that fractionation decreased the antimicrobial activity of the n-BuOH extract and did not affect that of the EtOAc extract. The ndings of the present study revealed that the MeOH, n-BuOH and EtOAc extracts from T. baccarinii showed different degrees of antimicrobial activities against bacterial and fungal strains. Differences observed in the antimicrobial activities of extracts can be linked to the differences in their chemical composition whereas variations in the susceptibility of tested microorganisms can be explained by the genetic differences between the strains. The result of the present study reveals the potential of T. baccarinii as a source of antibacterial and antifungal drugs and provides scienti c evidence for its use in folk medicine for the treatment of various infectious diseases. To our knowledge, no previous publications have reported the antibacterial and antifungal activities of T. baccarinii. So, this plant can be used as a novel therapeutic agent to prevent the progress of various infectious diseases particularly those caused by the tested microorganisms. In addition, this is the rst study using the spectroscopic methods for identi cation of chemical constituents from T. baccarinii in which known compounds have been identi ed for the rst time in this plant. According to the antimicrobial cutoff points de ned in the literature for plant extract 33 , the MeOH and EtOAc extracts of T. baccarinii were highly active (MIC < 100 μg/mL) against all the tested microorganisms whereas the n-BuOH extract was signi cantly active (100 ≤ MIC ≤ 512 μg/mL) against the tested microorganisms.
The microbicidal properties of extracts and isolated compounds against susceptible strains were analysed by the minimum microbicidal concentration (MMC) assay. Indeed, an antimicrobial agent is considered microbicidal if the MMC is not more than fourfold higher than the MIC, i.e. MMC/MIC ≤ 4 22 . The MeOH, EtOAc and n-BuOH extracts as well as compounds 1-6 and 8 were shown to be microbicidal (MMC/MIC ≤ 2) against the susceptible microorganisms with exception of the n-BuOH extract against E. coli and methicillin resistant S. aureus (MRSA04); compounds 6 and 8, against methicillin resistant S. aureus (MRSA03 and MRSA04), C. albicans and C. neoformans, with the MMC values being eightfold higher than the MIC indicating bacteriostatic character. These results suggest that the bacteriostatic/fungistatic and bactericidal/fungicidal activities of the n-BuOH extract and compounds 6 and 8 are dependent on the microbial strain. This behaviour is different to standard antibiotics, oxacillin and nystatin, which displayed microbicidal activities (MMC/MIC ≤ 4) against all the tested microorganisms.
Considering the antimicrobial cutoff points of pure compounds de ned in a previous report 33 , the antimicrobial activities of test compounds could be considered as signi cant/moderate (for compounds 3 and 5); moderate (for compounds 1 and 4); moderate/low (for compounds 2, 6 and 8); low/not active (for compounds 9 and 10); not active for compound 7 against speci c microorganism.
All of the compounds that were found to be active in the present study are members of saponins and avonoid groups. Although saponin and avonoid compounds have been reported to possess antibacterial and antifungal activities 9,21 , no study has reported the activity of compounds 1-6, 8 and 10 on the types of pathogenic microbial strains used in the present study. The mechanism of action of saponin (10) is not fully understood, but it may involve membrane disruption by lipophilic compounds 34 . The mechanism of action of avonoids (1)(2)(3)(4)(5)(6)(8)(9) is still to be studied; nevertheless, their activity may be due to the disruption of microbial membranes and their ability to complex bacterial cell walls, extracellular and soluble proteins 35  The results of the present study demonstrated that the n-BuOH extract was the most potent antioxidant extract among the extracts whereas compounds 1-4 and 6 were the most active antioxidant compounds. This nding suggests that the n-BuOH extract and compounds 1-4 and 6 are the best candidates to combat diseases associated with oxidative stress. These results are consistent since reactive oxygen species (ROS) generated from activated neutrophils and macrophages have been reported to play an important role in the pathogenesis of various diseases, including neurodegenerative disorders, cancer and atherosclerosis 36 . This is very promising in terms of discovering antioxidants from plants. Previous studies recorded that phenolic compounds including flavonoids and their glycosides are associated with strong antioxidant activity and they possess healthy bene ts 22,37 . Finally, the phytoconstituents and antioxidant / antimicrobial properties of extracts and isolated compounds from T. baccarinii are now well established in this study. These results clearly justify the uses of T. baccarinii in the treatment of various infectious diseases caused by the tested microorganisms and other ailments associated with oxidative stress.
The result on the bacteriolytic activity showed a decrease in the optical density of bacteria suspensions treated with the MeOH extract and compound 5 as a function of time; indicating the lysis of bacterial cells. Interestingly, none of the tested extracts and compounds showed cytotoxic activity against normal cells. These ndings highlight the selective toxicity of the tested samples towards the studied microorganisms. Previous studies demonstrated that some antimicrobial agents cause gross membrane damage 9,38 ; and this has been reported previously for avonoid glycosides from G. grandulosum 9 and for essential oils from rosewood, oregano, and thyme 38 . The effect of MeOH extract and compound 5 to lyse P. aeruginosa and S. aureus cells suggests that their primary mechanism of action is gross cell wall damage.
Sublethal injury of microbial cell membranes may alter their permeability and affect the membrane's ability to exclude toxic materials or to osmoregulate the cell adequately 39 . Consequently, the loss of tolerance to salts or other potentially toxic compounds may be exploited to reveal membrane damage 40 in sublethally injured bacteria. Treatment of S. aureus with different concentrations of MeOH extract/compound 5 signi cantly reduced the number of colony-forming units on media containing NaCl. This effect was most marked on culture medium supplemented at 70% NaCl with two times the MICs. These results correlate well with the bacteriolysis results since, in each case, treatment with MeOH extract / compound 5 at two times the MICs induced the loss of salt tolerance and bacteriolytic effect.
Treatment with MeOH extract/compound 5 caused reduction of superoxide dismutase (SOD) level in S. aureus strains. Indeed, SOD, which catalyzes the dismutation of superoxide into hydrogen peroxide is the rst line defence in bacterial cells against reactive oxygen species 41 . S. aureus was facilitated by two major SODs such as SOD-A and SOD-M, the former is mainly involved in endogenous stress while the latter is induced in exogenous stress 41 . allylpyrocatechol and catechin also reduced the catalase activity and caused toxicity in S. aureus 44,[46][47][48] . Altogether results suggest that the MeOH extract and compound 5 are promising lead candidates with antibacterial potential against MRSA. Thus, these samples exhibited antibacterial activity through bacteriolytic effect and reduction of the antioxidant defenses in the bacterial cells.
Given the results obtained in the present study, we can conclude that the puri cation of the EtOAc and n-BuOH extracts from T. baccarinii led to the isolation and characterization of ten known compounds namely: biochanin A (1), formononetin (2), luteolin (3), luteolin-4'-O-β-D-glucopyranoside (4), 4,7,2'-trihydroxy-4'-methoxyiso avanol (5), sissotrin (6), 1-methyl-β-D-glucopyranoside (7), ononin (8), D-mannitol (9) and 3-O-β-Dglucuronopyranosylsoyasapogenol B (10). The MeOH, EtOAc and n-BuOH extracts as well as compounds 1-6 from T. baccarinii displayed the most antimicrobial and antioxidant activities. The MeOH extract and compound 5 exhibited antibacterial activity through bacteriolytic effects and reduction of the antioxidant defenses in the bacterial cells. To the best of our knowledge, this is the rst report on the mechanisms of antibacterial action of MeOH extract and compound 5 from T. baccarinii against pathogenic strains. Interestingly, none of the tested extracts/compounds showed cytotoxic activity against normal cells; highlighting their good selectivity toward pathogenic bacteria and yeasts. The MeOH extract and compound 5 are promising lead candidates with antibacterial potential against MRSA. Hence, they can be utilized to ght against infectious diseases caused by the tested microorganisms and to combat diseases that induce oxidative stress.

Declarations
Availability of data and materials The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. Bacteriolytic effect of MeOH extract and compounds 5 against P. aeruginosa and S. aureus. Results represent the mean ± standard deviation of the triplicate OD at each incubation time.